What is an empiric antibiotic commonly used for acute pyelonephritis in adults?

What is an empiric antibiotic commonly used for acute pyelonephritis in adults?

• A. Ciprofloxacin
• B. Amoxicillin
• C. Azithromycin
• D. Cephalexin

Answer: (A)

Acute pyelonephritis is typically caused by gram-negative bacteria like E. coli, so the chosen empiric therapy should reliably cover these organisms and reach adequate levels in renal tissue and urine. Ciprofloxacin, a fluoroquinolone, does just that: it penetrates kidney tissue well and achieves high urinary concentrations, making it effective for kidney infections while you’re waiting for culture results. Amoxicillin is increasingly limited by resistance among urinary pathogens, so it’s not a reliable first-line pick. Azithromycin isn’t suitable for UTIs because it doesn’t achieve meaningful concentrations in the urine and has limited activity against common UTI pathogens. Cephalexin can cover some organisms but often isn’t reliable against E. coli in pyelonephritis and has less optimal renal tissue penetration for an upper urinary tract infection. So the best empiric choice among these options is ciprofloxacin.

Acute pyelonephritis is typically caused by gram-negative bacteria like E. coli, so the chosen empiric therapy should reliably cover these organisms and reach adequate levels in renal tissue and urine. Ciprofloxacin, a fluoroquinolone, does just that: it penetrates kidney tissue well and achieves high urinary concentrations, making it effective for kidney infections while you’re waiting for culture results. Amoxicillin is increasingly limited by resistance among urinary pathogens, so it’s not a reliable first-line pick. Azithromycin isn’t suitable for UTIs because it doesn’t achieve meaningful concentrations in the urine and has limited activity against common UTI pathogens. Cephalexin can cover some organisms but often isn’t reliable against E. coli in pyelonephritis and has less optimal renal tissue penetration for an upper urinary tract infection. So the best empiric choice among these options is ciprofloxacin.